| Literature DB >> 31894652 |
Sándor B Ötvös1, C Oliver Kappe1,2.
Abstract
Reductions of amides andEntities:
Keywords: amides; boranes; continuous flow; esters; reduction
Year: 2020 PMID: 31894652 PMCID: PMC7187139 DOI: 10.1002/cssc.201903459
Source DB: PubMed Journal: ChemSusChem ISSN: 1864-5631 Impact factor: 8.928
Figure 1Continuous‐flow reactor setup for the BH3⋅DMS‐mediated reductions.
Effects of various reaction parameters on the neat BH3⋅DMS‐mediated ester reduction under continuous‐flow conditions (see Figure 1).[a]
|
| |||||||
|---|---|---|---|---|---|---|---|
|
Entry |
[ |
[°C] |
Flow rate [μL min−1] |
Substr./BH3⋅DMS ratio |
[min] |
Conv.[b] [%] | |
|
|
|
|
P1 |
P2 |
|
|
|
|
1 |
2 |
50 |
250 |
150 |
1:3.0 |
30 |
42 |
|
2 |
2 |
90 |
250 |
150 |
1:3.0 |
30 |
100 |
|
3 |
2 |
90 |
310 |
90 |
1:1.5 |
30 |
97 |
|
4 |
2 |
90 |
330 |
70 |
1:1.1 |
30 |
85 |
|
5 |
2 |
90 |
570 |
230 |
1:2.0 |
15 |
96 |
|
6 |
2 |
90 |
620 |
180 |
1:1.5 |
15 |
92 |
|
7 |
2 |
90 |
450 |
150 |
1:1.7 |
20 |
97 |
|
8 |
2 |
90 |
430 |
170 |
1:2.0 |
20 |
100 |
|
9 |
4 |
90 |
330 |
270 |
1:2.0 |
20 |
100 (99)[c] |
|
10 |
8 (neat) |
90 |
230 |
370 |
1:2.0 |
20 |
100 (99)[c] |
[a] No side product formation, chemoselectivity was 100 % in all reactions. [b] Determined by 1H NMR spectroscopy of the crude product. [c] Yield of isolated product in parentheses.
Substrate scope of the neat BH3⋅DMS‐mediated ester reduction under continuous‐flow conditions (see Figure 1 for the flow setup).[a]
|
Entry |
Substrate |
Product |
[ |
Conv.[b] [%] |
Sel.[b] [%] |
|---|---|---|---|---|---|
|
1[c] |
|
|
4 |
100 (99)[d] |
100 |
|
2[c] |
|
|
4 |
100 |
100 |
|
3[c] |
|
|
4 |
98 |
100 |
|
4[e] |
|
|
2 |
93 |
100 |
|
5[c] |
|
|
4 |
100 (99)[d] |
100 |
|
6[c] |
|
|
4 |
100 |
100 |
|
7[c] |
|
|
4 |
100 |
100 |
|
8[c] |
|
|
4 |
100 |
100 |
|
9[c] |
|
|
4 |
99 |
100 |
|
10[c] |
|
|
4 |
98 |
100 |
|
11[c] |
|
|
4 |
100 (98)[d] |
100 |
|
12[c] |
|
|
4 |
100 |
100 |
|
13[c] |
|
|
4 |
95 |
100 |
|
14[c] |
|
|
4 |
96 |
100 |
|
15[c] |
|
|
4 |
99 |
100 |
|
16[f] |
|
|
1 |
67 |
99[g] |
|
17[h] |
|
|
1 |
94 |
98[g] |
|
18[i] |
|
|
0.6 |
100 |
89[j] |
|
19[k] |
|
|
0.6 |
100 |
100 |
|
20[e] |
|
|
2 |
100 (97)[d] |
100 |
|
21[f] |
|
|
1 |
100 |
100 |
|
22[c] |
|
|
4 |
100 |
100 |
|
23[e] |
|
|
2 |
100 |
100 |
|
24[e] |
|
|
2 |
100 (99)[d] |
100 |
|
25[c] |
|
|
4 |
100 |
100 |
|
26[c] |
|
|
4 |
100 (95)[d] |
100 |
|
27[c] |
|
|
4 |
100 |
100 |
|
28[c] |
|
|
4 |
100 |
100 |
[a] Reaction conditions: substrate in 2‐MeTHF, T=90 °C, t r=20 min. [b] Determined by 1H NMR spectroscopy of the crude product. [c] P1 at 330 μL min−1, P2 at 270 μL min−1, substrate/BH3⋅DMS ratio 1:2.0. [d] Yield of isolated product in parentheses. [e] P1 at 430 μL min−1, P2 at 170 μL min−1, substrate/BH3⋅DMS ratio 1:2.0. [f] P1 at 500 μL min−1, P2 at 100 μL min−1, substrate/BH3⋅DMS ratio 1:2.0. [g] Minor product: 3‐aminobenzyl alcohol. [h] P1 at 430 μL min−1, P2 at 170 μL min−1, substrate/BH3⋅DMS ratio 1:4.0. [i] P1 at 510 μL min−1, P2 at 90 μL min−1, substrate/BH3⋅DMS ratio 1:2.9. [j] Minor product: methyl 4‐(1‐hydroxyethyl)benzoate. [k] P1 at 490 μL min−1, P2 at 110 μL min−1, substrate/BH3⋅DMS ratio 1:3.7.
Reduction of various amides with neat BH3⋅DMS under continuous‐flow conditions (see Figure 1 for the flow setup).[a]
|
Entry |
Substrate |
Product |
[ |
Conv.[c] [%] |
Sel.[c] [%] |
|---|---|---|---|---|---|
|
1[d] |
|
|
1 (2‐MeTHF) |
100 (98)[e] |
100 |
|
2[f] |
|
|
0.6 (THF) |
96 |
100 |
|
3[f] |
|
|
0.6 (THF) |
98 |
100 |
|
4[d] |
|
|
1 (2‐MeTHF) |
100 |
100 |
|
5[d] |
|
|
1 (THF) |
100 |
100 |
|
6[f] |
|
|
0.6 (THF) |
100 |
100 |
|
7[f] |
|
|
0.6 (THF) |
100 (96)[e] |
100 |
|
8[d] |
|
|
1 (2‐MeTHF) |
100 |
100 |
|
9[d] |
|
|
1 (2‐MeTHF) |
100 (96)[e] |
100 |
|
10[f] |
|
|
0.6 (THF) |
100 |
100 |
|
11[g] |
|
|
0.3 (2‐MeTHF) |
100 |
100 |
|
12[g] |
|
|
0.3 (THF) |
100 |
100 |
|
13[h] |
|
|
1 (2‐MeTHF) |
100 (95)[e] |
100 |
|
14[d] |
|
|
1 (2‐MeTHF) |
100 |
100 |
|
15[f] |
|
|
0.6 (THF) |
88 (81)[e] |
100 |
|
16[d] |
|
|
1 (2‐MeTHF) |
98 |
85[i] |
|
17[d] |
|
|
1 (2‐MeTHF) |
100 |
100 |
|
18[f] |
|
|
0.6 (2‐MeTHF) |
100 |
100 |
|
19[f] |
|
|
0.6 (THF) |
100 |
100 |
|
20[f] |
|
|
0.6 (2‐MeTHF) |
98 |
100 |
|
21[f] |
|
|
0.6 (THF) |
84 |
100 |
[a] Reaction conditions: T=90 °C, t r=20 min. [b] Solvent used is shown in parentheses. [c] Determined by 1H NMR spectroscopy of the crude product. [d] P1 at 500 μL min−1, P2 at 100 μL min−1, substrate/BH3⋅DMS ratio 1:2.0. [e] Yield of isolated product. [f] P1 at 530 μL min−1, P2 at 70 μL min−1, substrate/BH3⋅DMS ratio 1:2.2. [g] P1 at 560 μL min−1, P2 at 40 μL min−1, substrate/BH3⋅DMS ratio 1:2.4. [h] P1 at 430 μL min−1, P2 at 170 μL min−1, substrate/BH3⋅DMS ratio 1:4.0. [i] Minor product: benzylamine.
Figure 2Continuous‐flow synthesis of pharmaceutically relevant products. (Substrate feed: 330 μL min−1 for A and 500 μL min−1 for B. Reducing agent feed: 270 μL min−1 for A and 100 μL min−1 for B. See also Figure 1).